Akzo Nobel Crecimiento futuro
Future controles de criterios 1/6
Se prevé un crecimiento anual de los beneficios y los ingresos de Akzo Nobel de 8.5% y 2.1% por año respectivamente. Se prevé que el BPA crezca en un 8.8% al año. Se espera que la rentabilidad financiera sea de 14.6% en 3 años.
Información clave
8.5%
Tasa de crecimiento de los beneficios
8.85%
Tasa de crecimiento del BPA
| Crecimiento de los beneficios de Chemicals | 20.0% |
| Tasa de crecimiento de los ingresos | 2.1% |
| Rentabilidad financiera futura | 14.57% |
| Cobertura de analistas | Good |
| Última actualización | 04 Jun 2026 |
Actualizaciones recientes sobre el crecimiento futuro
Recent updates
Actualización de narrativa • Jun 02
AKZA: Margin Delivery And Downgrade Reset Will Shape Fairly Valued Repricing
Akzo Nobel's analyst price target has been cut by around €1 to €61, as analysts factor in more cautious assumptions on revenue growth and profitability following recent target reductions and downgrades from several major banks. Analyst Commentary Recent Street research on Akzo Nobel clusters around a series of target cuts and rating downgrades, with most analysts reworking their valuation frameworks to reflect more cautious assumptions on revenue growth and profitability.Actualización de narrativa • May 02
AKZA: Margin Execution Is Expected To Support Repricing After Recent Downgrades
Akzo Nobel's updated analyst price target edges lower to about €62.60, as analysts factor in Street target cuts and downgrades, a slightly higher discount rate, and a more conservative future P/E assumption, despite using stronger revenue growth and profit margin inputs. Analyst Commentary Recent Street research on Akzo Nobel has focused on resetting expectations, with several firms lowering price targets and issuing downgrades.Actualización de narrativa • Apr 17
AKZA: Margin Delivery Is Expected To Support Repricing After Recent Downgrades
Akzo Nobel's analyst price target has been trimmed by about €1.35. This reflects analysts' updated assumptions for slightly softer revenue growth and valuation multiples, partly balanced by a small uplift in expected profit margins.
Nueva narrativa • Apr 16
Merger Synergies And Cost Programs Will Create A More Powerful Coatings Leader
Catalysts About Akzo Nobel Akzo Nobel is a global paints and coatings company serving decorative, industrial, automotive, marine, aerospace and packaging customers. What are the underlying business or industry changes driving this perspective?Actualización de narrativa • Apr 03
AKZA: Rebased Earnings And Margins Are Expected To Support Upside Repricing
Akzo Nobel's analyst fair value estimate has been trimmed by €2 to €65, as analysts factor in a series of recent downgrades and lower price targets, along with updated assumptions for growth, margins and future P/E levels. Analyst Commentary Recent Street research on Akzo Nobel presents a mix of cautious and constructive views, with several downgrades and price target cuts offset by at least one upward adjustment to fair value.
Nueva narrativa • Apr 02
Cost Synergies And Portfolio Pruning Will Shape A Steady Long Term Coatings Platform
Catalysts About Akzo Nobel Akzo Nobel is a global paints and coatings company supplying decorative paints and performance coatings to customers across construction, industrial and transportation end markets. What are the underlying business or industry changes driving this perspective?Actualización de narrativa • Mar 20
AKZA: Rebased Earnings Assumptions Will Support Upside Repricing Potential
Akzo Nobel's updated analyst price target has shifted modestly to €67.00, as analysts factor in a slightly higher discount rate, more conservative revenue growth and profit margin assumptions, and recalibrated P/E expectations despite mixed recent research views on the stock. Analyst Commentary Recent research on Akzo Nobel reflects a mix of optimism around upside potential and caution around execution risk, which together help explain the updated €67.00 price target.Artículo de análisis • Feb 15
We Think You Should Be Aware Of Some Concerning Factors In Akzo Nobel's (AMS:AKZA) Earnings
Akzo Nobel N.V.'s ( AMS:AKZA ) healthy profit numbers didn't contain any surprises for investors. We believe that...Actualización de narrativa • Feb 05
AKZA: Axalta Merger Will Expand Scale And Recast Earnings Potential
Narrative Update The analyst price target for Akzo Nobel is updated to €68.12 from €69.65, reflecting mixed research views. Some analysts cite more measured expectations around the Axalta merger, muted coatings growth and a modest synergy timeline, while others maintain higher targets closer to €75 supported by their own assessments.Actualización de narrativa • Jan 18
AKZA: Axalta Merger Will Reshape Scale And Earnings Profile
Analysts have nudged their fair value estimate for Akzo Nobel to €69.65 from €68.94, reflecting updated assumptions around revenue growth, margins and the Axalta merger, which align with recent Street price target moves between €59 and €75. Analyst Commentary Recent Street research around Akzo Nobel and its merger with Axalta provides a mixed but useful set of signals to consider when thinking about valuation, execution risk and growth potential.Artículo de análisis • Jan 12
Akzo Nobel (AMS:AKZA) Could Be At Risk Of Shrinking As A Company
When researching a stock for investment, what can tell us that the company is in decline? When we see a declining...Artículo de análisis • Dec 05
Is Akzo Nobel (AMS:AKZA) Using Too Much Debt?
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Artículo de análisis • Oct 22
Why Investors Shouldn't Be Surprised By Akzo Nobel N.V.'s (AMS:AKZA) P/E
With a price-to-earnings (or "P/E") ratio of 25.2x Akzo Nobel N.V. ( AMS:AKZA ) may be sending bearish signals at the...Artículo de análisis • Oct 09
Are Investors Undervaluing Akzo Nobel N.V. (AMS:AKZA) By 43%?
Key Insights Using the 2 Stage Free Cash Flow to Equity, Akzo Nobel fair value estimate is €105 Akzo Nobel's €59.94...Artículo de análisis • Aug 31
Is Akzo Nobel (AMS:AKZA) Using Too Much Debt?
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Artículo de análisis • Aug 18
Is Now An Opportune Moment To Examine Akzo Nobel N.V. (AMS:AKZA)?
ENXTAM:AKZA 1 Year Share Price vs Fair Value Explore Akzo Nobel's Fair Values from the Community and select yours Let's...Artículo de análisis • Jul 17
Akzo Nobel N.V.'s (AMS:AKZA) Price In Tune With Earnings
When close to half the companies in the Netherlands have price-to-earnings ratios (or "P/E's") below 19x, you may...Artículo de análisis • Jun 21
Akzo Nobel's (AMS:AKZA) Returns Have Hit A Wall
There are a few key trends to look for if we want to identify the next multi-bagger. Ideally, a business will show two...
Nueva narrativa • Nov 19
Steady Streamlining And Strategic Expansion Ignite A Brighter Future
Efficiency programs and workforce reductions are set to bolster net margins through significant cost savings.Previsiones de crecimiento de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Flujo de caja libre | Flujo de caja operativo | Núm. de analistas medio |
|---|---|---|---|---|---|
| 12/31/2028 | 10,466 | 739 | 669 | 1,075 | 15 |
| 12/31/2027 | 10,277 | 673 | 649 | 1,062 | 17 |
| 12/31/2026 | 10,035 | 551 | 592 | 909 | 18 |
| 3/31/2026 | 9,931 | 622 | 645 | 941 | N/A |
| 12/31/2025 | 10,158 | 636 | 605 | 914 | N/A |
| 9/30/2025 | 10,405 | 59 | 526 | 849 | N/A |
| 6/30/2025 | 10,526 | 415 | 478 | 812 | N/A |
| 3/31/2025 | 10,684 | 467 | 392 | 728 | N/A |
| 12/31/2024 | 10,711 | 542 | 362 | 668 | N/A |
| 9/30/2024 | 10,621 | 565 | 536 | 842 | N/A |
| 6/30/2024 | 10,694 | 592 | 561 | 844 | N/A |
| 3/31/2024 | 10,651 | 534 | 733 | 998 | N/A |
| 12/31/2023 | 10,668 | 447 | 834 | 1,120 | N/A |
| 9/30/2023 | 10,745 | 411 | 572 | 840 | N/A |
| 6/30/2023 | 10,866 | 309 | 375 | 661 | N/A |
| 3/31/2023 | 10,978 | 303 | 8 | 305 | N/A |
| 12/31/2022 | 10,846 | 362 | -38 | 254 | N/A |
| 9/30/2022 | 10,643 | 540 | -155 | 140 | N/A |
| 6/30/2022 | 10,191 | 616 | 20 | 313 | N/A |
| 3/31/2022 | 9,849 | 758 | 245 | 533 | N/A |
| 12/31/2021 | 9,587 | 823 | 316 | 604 | N/A |
| 9/30/2021 | 9,393 | 805 | 750 | 1,041 | N/A |
| 6/30/2021 | 9,259 | 866 | 922 | 1,207 | N/A |
| 3/31/2021 | 8,735 | 741 | 1,078 | 1,347 | N/A |
| 12/31/2020 | 8,530 | 637 | 959 | 1,217 | N/A |
| 9/30/2020 | 8,563 | 544 | 817 | 1,052 | N/A |
| 6/30/2020 | 8,685 | 481 | 681 | 904 | N/A |
| 3/31/2020 | 9,149 | 567 | 524 | 747 | N/A |
| 12/31/2019 | 9,276 | 517 | N/A | 23 | N/A |
| 9/30/2019 | 9,342 | 477 | N/A | 210 | N/A |
| 6/30/2019 | 9,270 | 463 | N/A | 220 | N/A |
| 3/31/2019 | 9,265 | 354 | N/A | 84 | N/A |
| 12/31/2018 | 9,256 | 400 | N/A | 513 | N/A |
| 9/30/2018 | 9,231 | 393 | N/A | 652 | N/A |
| 6/30/2018 | 9,324 | 365 | N/A | 671 | N/A |
| 3/31/2018 | 9,411 | 426 | N/A | 882 | N/A |
| 12/31/2017 | 9,612 | 439 | N/A | 969 | N/A |
| 9/30/2017 | 6,022 | 107 | N/A | 772 | N/A |
| 6/30/2017 | 7,203 | 272 | N/A | 1,035 | N/A |
| 3/31/2017 | 8,381 | 417 | N/A | 1,261 | N/A |
| 12/31/2016 | 9,434 | 534 | N/A | 1,291 | N/A |
| 9/30/2016 | 14,300 | 1,032 | N/A | 1,477 | N/A |
| 6/30/2016 | 14,460 | 1,031 | N/A | 1,460 | N/A |
| 3/31/2016 | 14,698 | 1,051 | N/A | 1,414 | N/A |
| 12/31/2015 | 14,859 | 973 | N/A | 1,130 | N/A |
| 9/30/2015 | 14,817 | 772 | N/A | 784 | N/A |
| 6/30/2015 | 14,743 | 691 | N/A | 679 | N/A |
Previsiones de crecimiento futuro de los analistas
Ingresos vs. Tasa de ahorro: El pronóstico de crecimiento de los beneficios (8.5% al año) de AKZA es superior a la tasa de ahorro (2.1%).
Beneficios vs. Mercado: Se prevé que los beneficios (8.5% al año) de AKZA crezcan menos que el mercado Dutch (14.6% al año).
Beneficios de alto crecimiento: Se prevé que los beneficios de AKZA crezcan, pero no significativamente.
Ingresos vs. Mercado: Se prevé que los ingresos (2.1% al año) de AKZA crezcan más despacio que el mercado de Dutch (10.2% al año).
Ingresos de alto crecimiento: Se prevé que los ingresos 2.1% al año) de AKZA crezcan más despacio que 20% al año.
Previsiones de crecimiento de los beneficios por acción
Rentabilidad financiera futura
ROE futura: Se prevé que la rentabilidad financiera de AKZA sea baja dentro de 3 años (14.6%).
Descubre empresas en crecimiento
Análisis de la empresa y estado de los datos financieros
| Datos | Última actualización (huso horario UTC) |
|---|---|
| Análisis de la empresa | 2026/06/14 19:20 |
| Precio de las acciones al final del día | 2026/06/12 00:00 |
| Beneficios | 2026/03/31 |
| Ingresos anuales | 2025/12/31 |
Fuentes de datos
Los datos utilizados en nuestro análisis de empresas proceden de S&P Global Market Intelligence LLC. Los siguientes datos se utilizan en nuestro modelo de análisis para generar este informe. Los datos están normalizados, lo que puede introducir un retraso desde que la fuente está disponible.
| Paquete | Datos | Marco temporal | Ejemplo Fuente EE.UU. * |
|---|---|---|---|
| Finanzas de la empresa | 10 años |
| |
| Estimaciones del consenso de analistas | +3 años |
|
|
| Precios de mercado | 30 años |
| |
| Propiedad | 10 años |
| |
| Gestión | 10 años |
| |
| Principales avances | 10 años |
|
* Ejemplo para valores de EE.UU., para no EE.UU. se utilizan formularios y fuentes normativas equivalentes.
A menos que se especifique lo contrario, todos los datos financieros se basan en un periodo anual, pero se actualizan trimestralmente. Esto se conoce como datos de los últimos doce meses (TTM) o de los últimos doce meses (LTM). Más información.
Modelo de análisis y copo de nieve
Los detalles del modelo de análisis utilizado para generar este informe están disponibles en nuestra página de Github, también tenemos guías sobre cómo utilizar nuestros informes y tutoriales en Youtube.
Conozca al equipo de talla mundial que diseñó y construyó el modelo de análisis Simply Wall St.
Métricas industriales y sectoriales
Simply Wall St calcula cada 6 horas nuestras métricas sectoriales y de sección. Los detalles de nuestro proceso están disponibles en Github.
Fuentes analistas
Akzo Nobel N.V. está cubierta por 40 analistas. 18 de esos analistas presentaron las estimaciones de ingresos o ganancias utilizadas como datos para nuestro informe. Las estimaciones de los analistas se actualizan a lo largo del día.
| Analista | Institución |
|---|---|
| Katie Richards | Barclays |
| Jennifer Barker | Barclays |
| Robert Bate | Barclays |